Compare LCTX & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCTX | CODI |
|---|---|---|
| Founded | 1990 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.7M | 480.8M |
| IPO Year | 1996 | N/A |
| Metric | LCTX | CODI |
|---|---|---|
| Price | $1.51 | $5.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $6.00 | ★ $8.00 |
| AVG Volume (30 Days) | 1.1M | ★ 1.1M |
| Earning Date | 03-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 4.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,556,000.00 | N/A |
| Revenue This Year | $55.75 | $0.93 |
| Revenue Next Year | $2.96 | $6.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $0.37 | $4.58 |
| 52 Week High | $2.09 | $20.01 |
| Indicator | LCTX | CODI |
|---|---|---|
| Relative Strength Index (RSI) | 33.23 | 35.75 |
| Support Level | $0.94 | $5.30 |
| Resistance Level | $1.84 | $7.04 |
| Average True Range (ATR) | 0.11 | 0.42 |
| MACD | -0.04 | -0.18 |
| Stochastic Oscillator | 2.06 | 1.17 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.